Dementia with Lewy bodies versus pure Alzheimer disease: Differences in cognition, neuropathology, cholinergic dysfunction, and synapse density

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 5, 1997, Pages 499-508

  Samuel, William ^a,c   Alford, Michael ^a   Hofstetter, C Richard ^a   Hansen, Lawrence ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Alzheimer disease; CHAT; Cholinergic; Dementia; Lewy bodies; Synapse density

Indexed keywords

CHOLINE ACETYLTRANSFERASE; SYNAPTOPHYSIN;

AGED; ALZHEIMER DISEASE; ARTICLE; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; ENTORHINAL CORTEX; FEMALE; HUMAN; HUMAN TISSUE; LEWY BODY; MALE; NEOCORTEX; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SENILE PLAQUE; SYNAPSE;

EID: 0030781194     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199705000-00006     Document Type: Article

References (48)

1. Hansen LA, Galasko D. Lewy body disease. Curr Opin Neurol Neurosurg 1992;5:889-94
2. Hulette C, Mirra S, Wilkinson W, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IX. A prospective clinicopathological study of Parkinson's features in Alzheimer's disease. Neurology 1995;45:1991-95
3. Hansen LA, Masliah E, Terry RD, Mirra SS. A neuropathological subset of Alzheimer's disease with concomitant Lewy body disease and spongiform change. Acta Neuropathol (Berl) 1989;78:194-201
4. Hansen L, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer's disease: A clinical and pathologic entity. Neurology 1990;40:1-8
5. Lippa CF, Smith TW, Swearer JM. Alzheimer's disease and Lewy body disease: A comparative clinicopathological study. Ann Neurol 1994;35:81-88
6. Hansen LA, Samuel W. Criteria for Alzheimer disease and the nosology of dementia with Lewy bodies. Neurology 1997;48:126-31
7. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): Report of the CDLB international workshop. Neurology 1996;47:1113-24
8. Salmon DP, Galasko D, Hansen LA, et al. Neuropsychological deficits associated with diffuse Lewy body disease. Brain and Cognition 1996;31:148-65
9. McKeith IG, Fairbairn AF, Bothwell RA, et al. An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 1994;44:872-77
10. Samuel W, Galasko D, Masliah E, Hansen LA. Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. J Neuropathol Exp Neurol 1996;55:44-52
11. Galasko D, Katzman R, Salmon DP, Hansen L. Clinical and neuropathological findings in Lewy body dementias. Brain and Cognition 1996;31:166-75
12. Forstl H, Burns A, Luther P, Cairns N, Levy R. The Lewy-body variant of Alzheimer's disease: Clinical and pathological findings. Br J Psychiatry 1993;162:385-92
13. Lennox G, Lowe J, Landon M, et al. Diffuse Lewy body disease: Correlative neuropathology using anti-ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiatry 1989;52:1236-47
14. Langlais PJ, Thal L, Hansen L, Galasko D, Alford M, Masliah E. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies. Neurology 1993;43:1927-34
15. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59
16. Banshor C, Braak H, Fischer P, Jellinger KA. Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients. Neurosci Lett 1993;162:179-82
17. Terry RD, Masliah E, Salmon DP, et al. Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991;30:572-80
18. Masliah E, Mallory M, DeTeresa R, et al. Differing patterns of aberrant neuronal sprouting in Alzheimer's disease with and without Lewy bodies. Brain Res 1993;617:258-66
19. Wakabayashi K, Honer WG, Masliah E. Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body disease. Brain Res 1994;667:24-32
20. Alford MF, Masliah E, Hansen LA, Terry RD. A simple dotimmunolabeling assay for quantification of synaptophysin-like immunoreactivity in human brain. J Histochem Cytochem 1994;42:283-87
21. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44
22. Khachaturian Z. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1105
23. Mirra SS, Heyman A, McKeel MD, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86
24. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral gray matter of elderly subjects. Br J Psychiatry 1968;114:797-811
25. Fuld PA. Psychological testing in the differential diagnosis of the dementias. In: Katzman R, Terry RD, Bick KL, eds. Alzheimer's disease: Senile dementia and related disorders. New York: Raven Press, 1978:185-93
26. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98
27. Hansen LA, DeTeresa R, Davies P, Terry RD. Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease. Neurology 1988;38:48-54
28. Lennox G, Lowe J, Morrell K, et al. Antiubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease. J Neurol Neurosurg Psychiatry 1989;52:67-71
29. Lowe J. Lewy bodies. In: Calne DF, ed. Neurodegenerative diseases. Philadelphia: WB Saunders, 1994
30. Snedecor GW, Cochran WG. Statistical methods. 7th ed. Ames, IA: Iowa State University Press, 1980, Chapter 12
31. Olichney JM, Hansen LA, Galasko D, Saitoh T, Hofstetter CR, Katzman R, Thal LJ. The apolipoprotein E e4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 1996;47:190-96
32. Winer BJ, Brown DR, Michels KM. Statistical principles in experimental design. 3rd ed. New York, NY: McGraw-Hill, 1991, Chapter 3
33. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992;42:631-39
34. McKenzie JE, Edwards RJ, Gentleman SM, et al. A quantitative comparison of plaque types in Alzheimer's disease and senile dementia of the Lewy body type. Acta Neuropathol 1996;91:526-29
35. Strong C, Anderton BH, Perry RH, Perry EK, Ince PG, Lovestone S. Abnormally phosphorylated tau protein in senile dementia of Lewy body type and Alzheimer disease: Evidence that the disorders are distinct. Alz Dis Assoc Disord 1995;9:218-22
36. Dickson DW, Ruan D, Crystal HA, et al. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease. Neurology 1991;41:1402-9
37. Geddes JW, Snowdon DA, Soultanian NS, et al. Braak stages III-IV of Alzheimer-related neurofibrillary pathology are associated with mild memory loss, stages V-VI are associated with dementia: Findings from the Nun study. J Neuropathol Exp Neurol 1996;55:617
38. Samuel WS, Henderson VW, Miller CA. Severity of dementia in Alzheimer disease and neurofibrillary tangles in multiple brain regions. Alzheimer Dis Assoc Disord 1991;5:1-11
39. Samuel W, Terry RD, DeTeresa RD, Butters N, Masliah E. Clinical correlates of cortical and nucleus basalis pathology in Alzheimer's dementia. Arch Neurol 1994;51:772-78
40. Eagger S, Levy R, Sahakian B. Tacrine in Alzheimer's disease. Lancet 1991;337:989-92
41. Perry EK, Haroutunian V, Davis KL, et al. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. NeuroReport 1994;5:747-49
42. Levy R, Eagger S, Griffiths M, et al. Lewy bodies and response to tacrine. Lancet 1994;343:176
43. Liberini P, Memo M, Spano PF. Lewy body pathology and heterogeneity in Alzheimer's disease. JAMA 1995;274:1199
44. Liberini P, Spano P, Cuello AC. Comment on a paper by Forstl et al (1993). Br J Psychiatry 1993;162:693-94
45. Schmidt ML, Martin JA, Lee, V M-Y, Trojanowski JQ. Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders. Acta Neuropathol 1996;91:475-81
46. Kazee A, Han LY. Cortical Lewy bodies in Alzheimer's disease. Arch Pathol Lab Med 1995;119:448-53
47. Kim H, Gearing M, Mirra SS. Ubiquitin-positive CA2/3 neurites in hippocampus coexist with cortical Lewy bodies. Neurology 1995;45:1768-70
48. Bondareff W, Mountjoy CQ, Roth M. Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology 1982;32:164-68